Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 12/20 | 0.42 |
| ▸ | FAAH | O00519 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CTSK | P43235 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21596988 | 1.00 | EPHX1 (0.43) | EPHX1ACHEFAAHCA12CA1 | |
| SCHEMBL760648 | 0.98 | EPHX1 (0.40) | EPHX1ACHEFAAHCA12CA1 | |
| SCHEMBL759928 | 0.92 | EPHX1 (0.37) | EPHX1ACHEFAAHCA12CA1 | |
| SCHEMBL759990 | 0.84 | ACHE (0.32) | EPHX1ACHE | |
| SCHEMBL27577278 | 0.83 | EPHX1 (0.63) | EPHX1ACHEFAAH | |
| SCHEMBL21059244 | 0.83 | EPHX1 (0.63) | EPHX1ACHEFAAH | |
| SCHEMBL29172694 | 0.83 | EPHX1 (0.63) | EPHX1ACHEFAAH | |
| SCHEMBL28804144 | 0.83 | EPHX1 (0.63) | EPHX1ACHEFAAH | |
| SCHEMBL28212419 | 0.83 | ACHE (0.54) | EPHX1ACHECA12CA1CA2 | |
| SCHEMBL29163511 | 0.83 | EPHX1 (0.63) | EPHX1ACHEFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023151559-A1 | HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND ANTI-TUMOR USE THEREOF | 和径医药科技（上海）有限公司 | 2023-08-17 | — | — | WO | disclosed |
| CN-116531346-A | Nanometer medicine for cisplatin-resistant tumor glutamine interference therapy and preparation method and application thereof | 滨州医学院 | 2023-08-04 | — | — | CN | disclosed |